Elena Ros-Sanchez

Dr. Elena Ros-Sanchez

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
ERElena Ros-Sanchez
Elena Ros-Sanchez
DODavid Oliver-Gutierrez
David Oliver-Gutierrez
PBPaul Buck
Paul Buck
TGTetiana Goncharova
Tetiana Goncharova
LDLaura Distefano
Laura Distefano
EKEric Kirkegaard-Biosca
Eric Kirkegaard-Biosca
Purpose: To report a case of Purpureocillium lilacinum endophthalmitis. Methods: The case of a fungal endophthalmitis caused by Purpureocillium lilacinum documented in an immunocompetent patient with no apparent trigger. Results: A 64-year-old male with a two-month history of panuveitis in his left eye was referred to our hospital. Initially misdiagnosed as sympathetic ophthalmia due to a previous surgery on his right eye 4 months before the onset of the left ocular picture, the patient received corticosteroid treatment, leading to a rapid deterioration of the left eye condition. An urgent exploratory vitrectomy was performed to identify the underlying cause, revealing endophthalmitis. Microbiological investigation yielded Purpureocillium lilacinum as the causative agent. Despite intensive treatment, including intravitreal antibiotics and antifungals, along with another surgical intervention, clinical evolution remained unfavourable, ultimately leading to the evisceration of the affected eye. Conclusions: Purpureocillium lilacinum poses a rare yet sever threat as a causative agent of fungal endophthalmitis. Managing such cases is challenging due to the delayed identification, fungus’s resistance to common antifungals, and its association with prior corticosteroid misuse in most patients. This case underscores the crucial importance of heightened clinical suspicion, early diagnosis, and the exploration of alternative treatment strategies in addressing Purpureocillium lilacinum endophthalmitis. The challenges posed by this rare fungal pathogen emphasize the need for a multidisciplinary approach and continued research to improve outcomes in these complex cases.

17 November 2025 in Eye
Verified
Journal Article
Closed access
PDF file
ERElena Ros-Sanchez
Elena Ros-Sanchez
DODavid Oliver-Gutierrez
David Oliver-Gutierrez
RGRocío García-Risco
Rocío García-Risco
LGLiliana Gutuleac
Liliana Gutuleac
PBPaul Buck
Paul Buck
EKEric Kirkegaard-Biosca
Eric Kirkegaard-Biosca

23 September 2026 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ERElena Ros-Sanchez
Elena Ros-Sanchez
DODavid Oliver-Gutierrez
David Oliver-Gutierrez
SGSara García-Hidalgo
Sara García-Hidalgo
MLMarc Tort Lacambra
Marc Tort Lacambra
IFIgnacio Flores-Moreno
Ignacio Flores-Moreno
MZMiguel Angel Zapata
Miguel Angel Zapata

18 August 2025 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
ERElena Ros-Sanchez
Elena Ros-Sanchez
DODavid Oliver-Gutierrez
David Oliver-Gutierrez
PBPaul Buck
Paul Buck
TGTetiana Goncharova-Simón
Tetiana Goncharova-Simón
MGMarta Garrido-Marín
Marta Garrido-Marín
ABAnna Boixadera
Anna Boixadera
Choroidal melanoma is the most common primary intraocular malignancy, accounting for 90% of all uveal melanomas. Although radiation therapy (brachytherapy, proton beam and gamma knife) is a standard and effective treatment for choroidal melanomas, it carries a risk of vision-threatening complications such as cataract, optic neuropathy, and radiation retinopathy. A lesser-known complication is tumor-related lipid exudation (TRLE), characterized by subretinal and intraretinal lipid accumulation following radiotherapy, potentially resulting from radiation-induced vasculopathy and increased vascular permeability. We report a case of a 61-year-old man with a long-standing choroidal nevus under observation for 15 years. Due to signs of growth and subretinal fluid detected on OCT, malignancy was suspected, and Ruthenium-106 brachytherapy was performed. One-month post-treatment, the patient developed progressive exudative retinal detachment with lipid exudation, despite preserved visual acuity. At the nine-month follow-up, worsening exudation and tumor growth were observed, prompting a second brachytherapy session and intravitreal aflibercept injections every eight weeks, leading to complete resolution of lipid exudation and restoration of retinal anatomy. Six months post-treatment, the tumor remained flat, and visual acuity improved to 20/20. TRLE is an underrecognized complication of radiation therapy for choroidal melanoma, with risk factors including pre-radiotherapy subretinal fluid, increased tumour thickness, and Bruch’s membrane rupture. Studies suggest that anti-VEGF therapy may help mitigate exudative complications; however, its efficacy remains uncertain. This case highlights the importance of recognizing TRLE as a potential complication of brachytherapy and underscores the critical role of multimodal imaging in early diagnosis and monitoring, ensuring optimal treatment outcomes for patients with choroidal melanoma.

18 October 2025 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
ERElena Ros-Sanchez
Elena Ros-Sanchez
DOD. Oliver-Gutierrez
D. Oliver-Gutierrez
CPC. Parés-Alfonso
C. Parés-Alfonso
SPS. Alarcón Portabella
S. Alarcón Portabella
CWC. Wolley-Dod
C. Wolley-Dod
NBN. Martín Begué
N. Martín Begué

22 July 2025 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
TGT. Goncharova
T. Goncharova
MTM. Tort
M. Tort
YBYann Bertolani
Yann Bertolani
PBP. Buck
P. Buck
DOD. Oliver-Gutiérrez
D. Oliver-Gutiérrez
ABA. Boixadera
A. Boixadera